Pharmaceutical Market: 10 Year Forecast 2016
											Language:
										
									
											Japanese
										
									
											Product Code No:
										
									
											C57124400
										
									
											Issued In:
										
									
											2016/03
										
									
											#of Pages:
										
									
											188
										
									
											Publication Cycle:
										
									
											
																						Annual
											
										
									
											Format:
										
									
                                            												PDF
																					
									
											Geographic Coverage:
										
									
														Japan
											
									
											Industry:
										
									
											Jump to the Japanese Page:
										
									Coverage: (Product/service)
Pharmaceutical market
Research Target:
hospitals, pharmaceutical wholesalers, dispensing pharmacy chains, other pharmaceutical organizations, and related governmental agencies
Research Content:
I Medical Service System in Transition Period
- Reforms toward 2025 steadily becoming larger and larger
- Number of sickbeds needed in 2025
- Restructuring needed for hospital sickbeds
- What will change after local comprehensive care becoming available
- Pharmacies vacillating
II Distribution of Medicines in Transitional Period
- Favorable sales achieved by wholesalers due to special procurement demands for the drugs used to treat hepatitis c infections.
- Improvement needed in reaching agreement between pharmacies and pharmaceutical companies and in distribution of drugs
- Wholesalers after the revision of the medical payment system for FY2016
- How large the Influence of dispending fee revisions to wholesaling business
- Business management needed to cope with patent cliff
III Companies of Pharmaceutical Industry in Transitional Period
- New system to conduct revision every year and large exception to reduce prices for specific drugs with huge sales
- Long-term listed items that have long been one of characteristics of Japanese pharmaceutical market are to disappear.
- Existing drugs may be reincarnated as new drugs
- Can companies make "JPMA Industry Vision 2025" connected with their own growth?
- M&A should not be the keyword for growth
IV Drug Market in Transitional Period
- Great change in development of new drugs
- Number of patients is likely to continue growing despite no new effective drugs expected to appear
- Sales forecast of ethical pharmaceuticals in Japan (2015 to 2023)